Sandra Kummer

This paper develops a domain-adversarial neural network to predict drug combination synergy in leukemia patients using bulk transcriptomics data, showing improved accuracy over existing methods.

The paper uses drug perturbations and RNA sequencing to map pathway connectivity in CLL, showing how genetic aberrations modulate drug responses and pathway interactions.